Surfactant for the treatment of respiratory distress syndrome.
about
Calfactant.Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial)Lipid bilayer surface association of lung surfactant protein SP-B, amphipathic segment detected by flow immunofluorescence.Pulmonary surfactant and its apoproteins.Perinatal changes in lung surfactant calcium measured in situ.Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.Immunosuppression by pulmonary surfactant: mechanisms of action.Factors affecting surfactant responsiveness.Function and regulation of expression of pulmonary surfactant-associated proteins.Preterm factors influencing surfactant deficiency.Aerosols for systemic treatment.Role of alveolar type II cells and of surfactant-associated protein C mRNA levels in the pathogenesis of respiratory distress in mink kits infected with Aleutian mink disease parvovirus.Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery.Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system.Toxicologic testing of inhaled pharmaceutical aerosols.Liposomes in allergy and immunology.Corticosteroids and surfactant for prevention of neonatal RDS.Surfactant and the adult respiratory distress syndrome.Surfactant replacement therapy for adult respiratory distress syndrome in children.Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration.Corticosteroids and intratracheal surfactant both alter the distribution between the airways and lung tissue of intratracheally administered radiolabeled phosphatidylcholine in the preterm rabbit.Influence of bilirubin on surface tension properties of lung surfactant.Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.A conformation transition of lung surfactant lipids probably involved in respiration.Surfactant abnormalities in patients with respiratory failure after multiple trauma.Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome.Thrombin/antithrombin III complex formation in the neonatal respiratory distress syndrome.Effects of surfactant protein-A on surfactant function in preterm ventilated rabbits.Cumulative effects of repeated surfactant treatments in the rabbit.Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB.An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant.Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications.The Evolution of Bronchopulmonary Dysplasia after 50 Years.Morphology and function of pulmonary surfactant inhibited by meconium.Liposomes and pulmonary alveolar macrophages: functional and morphologic interactions.Nebulization of liposomal rh-Cu/Zn-SOD with a novel vibrating membrane nebulizer.Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit.A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.
P2860
Q30308001-89CD1381-7DD0-4631-AB96-F9AD2725F750Q33623794-51FC3FD7-6F7A-4B0F-8C1A-1C84B431FFCAQ34091756-BB5B361B-CB2E-45BA-A183-EFE48FE0570AQ34254562-83EC0F61-67F9-4FB6-90F1-074805847E2CQ35816176-C06F92DC-667D-4CBB-9D44-160F863F098CQ36233401-131382DC-2A1F-4F90-916A-25781D83EEFBQ36587463-C8C512DA-2641-4A74-AC8B-44E773F1B7E2Q36928292-2E340903-15D0-463F-9A50-2CF684165C48Q37632052-D356043A-9512-4DAA-9688-E60F4C1F9710Q37726132-1F780285-D86C-442E-BBD1-BFC962779DAEQ37822444-F448EBB9-CE57-42C4-AAAF-B81E94F6E4A7Q40040306-A2E6E782-7C9D-4745-A5A8-F216D4884F46Q40499123-674E9A2F-31CA-4836-815D-747E72C4F688Q40575234-1A7F90F2-2B0A-41A8-A348-61DEAC4B9588Q40738920-0F96C22E-0F8A-46F1-ABBC-8FE047A0DD08Q40772013-E7C793A0-BB92-4348-9D97-DDD48D1B0F97Q40826398-724704ED-7BDC-41A8-B720-F34470A4F170Q40869111-6A3D708B-5989-4E98-AFE7-DE750B0B216CQ41049441-969CE5C7-3CE6-457F-B805-CAB75BD8AFABQ41212988-8078FBBB-0A6D-40BA-A885-0FFA8BA00F8EQ41239643-C0568AD2-DAD5-407E-8C4F-02730A446162Q41883256-83045450-2BB0-441A-B05D-9AD4B23FDCE7Q41966523-8DE5BB99-DA91-4F83-B60D-DBFD5A63B514Q42088940-EAEDEC7F-6BF5-4139-B2D4-62B351C10CCDQ44143669-21C0B1AF-BD25-444A-9793-7D91CCA5D3AAQ44337052-307A899E-9DCF-45E5-BE90-2AD34344188EQ44590921-19AFF89D-1E3A-4DE8-B250-56471F41F5E3Q44657612-596A2015-8A7D-4818-9A49-B4AE118DF8B6Q45045908-F20BB7BC-40A3-4322-806C-A9C964D0F95BQ46107322-AE5EFF95-066E-4249-90F9-E3560305A042Q46440317-98132B56-3249-495F-BE20-833187E493C2Q46504389-AD856517-717C-41F0-9AE6-251804151036Q46686615-7FDEEA3D-8767-4CA8-A542-BB2990526CAAQ46799280-87E87C7B-28CD-4118-8884-FC57FA9F8FE6Q47575157-2B415187-612D-44E0-91AC-1FD1939E3DB3Q47692095-0003BE6E-7C63-475C-AE92-E4148500DF36Q50803012-8EB1BB42-1170-4F59-8D33-3AE9FABB370DQ51186869-B02BFD30-24E7-44CD-A409-6149C187EBF4Q51656273-EEE23245-1061-4F10-9ED4-FC2D07863109Q51691674-104A820D-74BE-40EB-90F2-1F29F03B9BA0
P2860
Surfactant for the treatment of respiratory distress syndrome.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Surfactant for the treatment of respiratory distress syndrome.
@en
Surfactant for the treatment of respiratory distress syndrome.
@nl
type
label
Surfactant for the treatment of respiratory distress syndrome.
@en
Surfactant for the treatment of respiratory distress syndrome.
@nl
prefLabel
Surfactant for the treatment of respiratory distress syndrome.
@en
Surfactant for the treatment of respiratory distress syndrome.
@nl
P2860
P356
P1476
Surfactant for the treatment of respiratory distress syndrome.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM/136.5.1256
P577
1987-11-01T00:00:00Z